PIPELINE

So far, we have focused on re-purposing existing compounds for possible use in epilepsy. Currently there are four compounds, including one approved drug, that are part of this process (see pipeline below). In convincing a specific company to pursue a compound it has been critical to have individuals within the company that can serve as champions for the re-purposing effort.